# Laboratorios Farmaceuticos Rovi, S.A. (LABFF)

> 医疗保健 · ES · 以 EUR 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/LABFF/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | € 344.74M | € 84.51M | € 63.73M | € 107.53M | € 700.62M |
| 2025 | € 755.56M | € 142.72M | € 122.20M | € 131.10M | € 664.17M |
| 2024 | € 791.26M | € 141.81M | € 78.80M | € 114.41M | € 572.03M |
| 2023 | € 880.26M | € 180.76M | € 61.61M | € 65.43M | € 539.39M |
| 2022 | € 892.93M | € 218.04M | € 203.35M | € 72.14M | € 520.01M |
| 2021 | € 773.52M | € 182.54M | € 129.38M | € 73.15M | € 470.98M |
| 2020 | € 525.68M | € 76.43M | € 8.99M | € 74.44M | € 373.70M |
| 2019 | € 475.96M | € 49.02M | € -61.87M | € 84.68M | € 322.39M |
| 2018 | € 383.52M | € 22.64M | € -22.68M | € 34.22M | € 287.47M |
| 2017 | € 353.96M | € 22.14M | € -2.45M | € 43.24M | € 191.69M |
| 2016 | € 345.09M | € 33.95M | € 35.72M | € 33.79M | € 183.41M |
| 2015 | € 323.66M | € 26.06M | € 12.49M | € 42.78M | € 164.79M |
| 2014 | € 313.95M | € 31.81M | € -2.71M | € 36.31M | € 158.47M |
| 2013 | € 286.49M | € 30.31M | € 6.76M | € 30.98M | € 144.46M |
| 2012 | € 332.78M | € 30.79M | € 7.83M | € 38.39M | € 126.45M |
| 2011 | € 310.82M | € 28.51M | € 5.88M | € 41.25M | € 113.98M |
| 2010 | € 221.28M | € 34.29M | € 21.78M | € 43.09M | € 104.13M |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.15 |
| 总负债 / 股东权益 | 0.59 |
| 流动比率 | 2.05 |

## 债务覆盖

| 指标 | 数值 |
| --- | --- |
| 总债务 / 盈利 | 0.95 |
| 总债务 / 自由现金流 | 1.81 |

## 其他视图

- [指标](https://sponda.capital/zh/LABFF.md)
- [图表](https://sponda.capital/zh/LABFF/charts.md)
- [对比](https://sponda.capital/zh/LABFF/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-29。